Skip to main content
. 2025 Oct 13;14(20):7219. doi: 10.3390/jcm14207219
ICI Immune checkpoint inhibitor
CTLA-4 Cytotoxic T-lymphocyte antigen 4
LAG-3 Lymphocyte activating gene 3
PD-1 Programmed cell death 1
PD-L1 Programmed cell death ligand 1
GI Gastro-intestinal
irAE Immune-related adverse event
CTCAE Common Terminology Criteria for Adverse Events
TNFα Tumor necrosis factor alpha
IBD Inflammatory bowel disease
CRP C-reactive protein
5-ASA 5-aminosalicylic acid